PROGRAMME

 

Lim Por Yen Theatre, G/F
Obstetrics
Pao Yue Kong Auditorium, G/F
Gynaecology
1 June 2019 (Sat)
0930-1000 Registration
1000-1130 High Risk Pregnancy – Part 1 Simulation
1130-1200 Opening Ceremony
(Run Run Shaw Hall, 1/F)
1200-1315 Lunch Symposium (Sponsored by Bayer)
(Run Run Shaw Hall, 1/F)
1315-1445 Fetal Medicine / Prenatal Genetics – Part 1 Colposcopy
1445-1530 Coffee break
1530-1700 Preventive Measures in Pregnancy Oncology
1700-1730 / OGSHK BGM
2 June 2019 (Sun)
0830-0900 Registration
0900-1030 Midwifery Ultrasound
1030-1100 Coffee break
1100-1230 High Risk Pregnancy – Part 2 Endoscopy
1230-1345 Lunch Symposium (Sponsored by GSK)
(Run Run Shaw Hall, 1/F)
1345-1515 Thrombophilia and Pregnancy Urogynaecology
1515-1530 Coffee break
1530-1700 Fetal Medicine / Prenatal Genetics – Part 2 Reproductive Medicine


OBSTETRICS

High Risk Pregnancy – Part 1
Chairpersons: Dr. Annie SY HUI, Dr. Meliza KONG
Cervical Length Measurement in Pregnancy - Who, When, Why?
Dr. Lai-Wa Law
(Hong Kong)
Twin Pregnancy with Short Cervix - What the Clinician Should Do?
Prof. Anthony O Odibo
(USA)
Hypertriglyceridaemia in Pregnancy – Its Life Threatening Complication and Management
Prof. Wing-Hung Tam
(Hong Kong)
back to top
Fetal Medicine / Prenatal Genetics – Part 1
Chairpersons: Dr. Yvonne KY CHENG, Dr. Charas ONG
Placental Vascularization and Development / Prediction of Fetal Growth Restriction
The objectives of this talk include:
Discuss the relationship between abnormal fetal growth and adverse pregnancy outcomes
Identify common indications for third-trimester ultrasound
Compare the evidence for and against routine third-trimester ultrasound screening.
Prof. Anthony O Odibo
(USA)
Placental Mosaicism and IUGR
Mosaicism is a well-known cause of intrauterine growth restriction (IUGR) which could present in both the placenta and the fetal tissue or confined in the placenta only. Confined placental mosaicism (CPM) is observed in about 1-2% of chorionic villus sampling. CPM is further classified into type 1, 2 and 3 according to the location of the placental abnormalities. The risk of IUGR is related to the type of CPM and the chromosome involved. CPM involving chromosomes related to imprinting effect are associated with higher risk of IUGR.
Dr. Olivia YM Chan
(Hong Kong)
Early Onset vs Late Onset IUGR
Prof. Tak-Yeung Leung
(Hong Kong)
Should All Women have Third Trimester Ultrasound Screening? What the Data Show
The participants will understand the role of placental vascularization in the functions of remodeling of Maternal tissues,delivery of oxygen and nutrients, protection of the fetus from infections and other toxic agents and in optimizing short and long-term fetal development. Finally we propose the potential role of aberrations in placental vascular development and the patho-physiology of fetal growth restriction.
Prof. Anthony O Odibo
(USA)
back to top
Preventive Measures in Pregnancy
Chairpersons: Dr. Wan-Pang CHAN, Dr. Lai-Wa LAW
How Much Folic Acid is Needed in Pregnancy?
Dr. Amelia PW Hui
(Hong Kong)
Should Antenatal Antiviral Medication be Given for Hepatitis B Carriers?
Prof. Ching-Lung Lai
(Hong Kong)
Timing of elective caesarean section and the use of prophylactic antenatal steroids at term
Dr. Danny LEUNG
(Hong Kong)
back to top
Midwifery
Chairpersons: Ms. Chit-Ying LAI, Ms. Lai-Fong HO
Continuity of Midwifery Care in Advancing Maternal and Neonatal Outcomes
Ms. Maureen COLLINS
(United Kingdom)
When Mindfulness Meets Hypnobirthing in a Gentle Birth Class
Studies showed that maternal anxiety during pregnancy could have serious negative effects on the health of the woman and her newborn. Stress and fear of childbirth would provoke dysfunctional labour and contribute debilitating effects on the women and their families. In accordance with WHO recommendations, antenatal health education intervention and support program were recommended to reduce unnecessary caesarean sections. Therefore, we commenced mindfulness practices to some high risks women in our department. After attending the class, 58% of the participants used mindful breathing to cope with the labour pain and no pharmacological pain relief was used. The couples also feedback their relationships were increased in intimacy. To enrich our antenatal preparation education, we developed a Gentle Birth Workshop aimed to reduce childbirth fear, empower the women with pain management techniques and encourage bonding with the newborns. The workshop was led by advanced practice midwives with 2 sessions which 6 hours in total. The content had four main constructs that were mindfulness, hypnosis, childbirth massage and infant massage. We used the Wijma Delivery Expectancy / Experience Questionnaires (W-DEQ) to assess the fear level in childbirth. The higher the score indicated the higher level of fear. Questionnaires were collected on the day they came to the workshop and after their deliveries. The pre-score was ranged from 63 to 103 and the post-score was ranged from 30 to 72. Overall had 16% to 62% decrease. The mean score of fear in childbirth was decreased by 34.3%. This indicated these women had a significant decrease in their fear level on childbirth after attending this workshop.
Ms. Kit-Yee LAM
(Hong Kong)
How to Facilitate Bonding Cesarean Birth in the Operating Theatre
In the last two decades, there were lots of effort on promoting early skin-to-skin contact, early breastfeeding and parental involvement soon after vaginal birth. The length of early skin-to-skin contact has a positive effect on breastfeeding duration. The longer a mother and newborn are in skin-to-skin contact, the longer the newborn exclusively breastfeeds. On another hand, caesarean section remains as surgical interventions. Women who give birth via Caesarean section are not offered the same opportunity for skin-to-skin contact with their newborns as women who deliver vaginally. As a result, women who undergo uncomplicated elective caesarean section have reported to less satisfaction childbirth experience than those delivering vaginally. They are prone to postnatal depression, bonding difficulties and unsuccessful breastfeeding. To improve the experience of women having uneventful pregnancy and uneventful Caesarean section, a private hospital offers the opportunity in early skin-to-skin contact and parental involvement starting from operating room. Midwife in operating theatre helps with placing the newborns onto mothers chest if the newborns are medically stable. There will be an uninterrupted maternal and newborn bonding time from operation theatre to postnatal rooms.
Ms. Ashley LAI
(Hong Kong)
back to top
High Risk Pregnancy – Part 2
Chairpersons: Dr. Wing-Cheong LEUNG, Dr. Tsz-Kin LO
High Risk Obstetric Bed in Labour Ward - Sharing of Experience
With the ageing maternity population and increasing complexity of coexistent diseases, there is a raising need for maternal critical care worldwide, with the aim of reducing maternal morbidity and mortality. In May 2018, a pilot project was initiated in the Prince of Wales Hospital, a “Maternal Special Care Bed” (“MSCB”) within the delivery suite was designated to provide level 1 and level 2 critical care, managed by a multidisciplinary team consisted of trained midwives, obstetricians and anaesthetists with additional training in critical care. The aim is to ensure that critically ill pregnant or postpartum women would receive up-to-standard care for both their pregnancy-related and critical conditions. In this presentation, I would like to share with you our experience so far, including the level of care provided by the MSCB and the disease spectrum we encountered and cared within the MSCB.
Dr. Annie SY Hui
(Hong Kong)
Confidential Enquires into Maternal Deaths in Hong Kong
There are wide variations in maternal mortality rates across different countries and geographical areas. The United Nations Millennium Development Goad (MDG 5a) called for a reduction in maternal mortality rate by 75% between 1990 and 2015, but this objective was only partially achieved with a reduction of 44%. Between 2016 and 2030, as part of the Sustainable Development Goals, the WHO targets is to reduce the global maternal mortality ratio to less than 70 per 100 000 live births. Many countries have their own formal of maternal mortality reports, the most well established being the triannual Confidential enquires into maternal deaths in the United Kingdom since 1952. The maternal mortality rates reported in Hong Kong has been one of the lowest in the world. While Hong Kong is unlikely to be able to follow the UK format due to various constraints and limitations, it remains controversial as to whether such maternal mortality enquires should or can be done in HK, or whether it can be done “confidentially”, or whether the government, the Hospital Authority, or our College should take up the role of conducting such enquires. The practical difficulties in conducting such enquires in Hong Kong will be discussed.
Dr. William WK To
(Hong Kong)
Venous Thromboembolism Prophylaxis Following Caesarean Section - A Local Risk Score Model and the International Guidelines
Obstetric venous thromboembolism VTE, although rare, is still a major cause of maternal mortality and morbidity. Recommendations for VTE prophylaxis from authoritative guidelines for women undergoing caesarean delivery differed significantly and may not be applicable to Chinese populations. We compared a local risk model for VTE prophylaxis for caesarean section women implemented in the obstetric unit of the United Christian Hospital since 2017 with the RCOG and ACOG guidelines and discuss the benefit and risk of VTE prophylaxis.
Dr. Irene WY Lok
(Hong Kong)
back to top
Thrombophilia and Pregnancy
Chairpersons: Prof. Wing-Hung TAM, Dr. Amelia PW HUI
Thrombophilia in Pregnancy Complications - To Screen or Not to Screen
Prof. Arya ROOPEN
(United Kingdom)
Pitfalls on Interpretation of Thrombophilia Screening and D Dimer in Pregnancy
Dr. Rock YY Leung
(Hong Kong)
Controversy in Management of Congenital Thromobophilia in Pregnancy
Prof. Arya ROOPEN
(United Kingdom)
Panel Discussion
back to top
Fetal Medicine / Prenatal Genetics – Part 2
Chairpersons: Prof. Kwok-Yin LEUNG, Dr. Ben CHAN
Screening Thalassemia by MCV Alone: What May be Missed?
Dr. Isabella YM Wah
(Hong Kong)
Expanded Carrier Screening
Dr. Tze-Kin Lau
(Hong Kong)
Risk of Congenital Abnormalities Related to Parental Consanguinity: Data from NTWC
Dr. Sidney KC Au Yeung
(Hong Kong)
Low-pass Sequencing for Fetal Genetic Diagnosis
Prof. Richard KW Choy
(Hong Kong)
back to top

GYNAECOLOGY

Simulation
Chairpersons: Dr. Kwok-Keung TANG, Dr. Daniel WONG
Overview of Simulation in Hong Kong
Dr. Kenny KC CHAN
(Hong Kong)
Simulation Centre Development
Simulation training in Paediatrics started in 2012 when the American Academy of Pediatrics agreed to introduce its Neonatal Resuscitation Program (NRP) in Hong Kong.

To date, five simulation training courses are mandatory for the paediatric trainees of the Hong Kong College of Paediatrics – Neonatal Resuscitation Program (NRP), Pediatric Advance Life Support (PALS), Safe Paediatric Sedation, Child Protection and Paediatric Palliative Care.

NRP and PALS are prerequisite for HA (Hospital Authority) nurses participating in PRCC (Post-registration Certificate Courses) in NICU and PICU.

In August, 2018, the Simulation Training Centre of the Hong Kong Children’s Hospital (ChildSim) opened. It is set up for all paediatrics-related simulation training in Hong Kong. In the first 10 months, we have run 34 classes of 8 simulation courses, with 779 learners successfully completed their training.

In the coming 10 months, we shall have a total of 12 courses including NRP, S.T.A.B.L.E., Safe Paediatric Sedation, Neonatal Emergency Transport Simulation (NETS), Paediatric ECMO, Paediatric Palliative Care, Paediatric Airway Intervention and Tracheostomy (PAInT), Paediatric Emergency Transport Simulation (PETS), Basic Life Support (BLS), Pediatric Advance Life Support (PALS), Clinical Handover and Child Protection.

To make the simulation training successful, the programs must be tailored precisely to the needs of the learners. These programs must be endorsed by Colleges or respectable professional societies. Simulation Instructors must be acknowledged and valued. The curriculum needs to be updated with respect to the prevailing clinical guidelines. The Simulation Training Centre must provide a safe and enjoyable learning environment. Debriefing is a challenging skill to master, especially locally. But once it becomes a “habit” for any real clinical and teaching events, it will be an extremely rewarding learning tool. Didactics are not welcome according to the feedback of the learners, except when delivered through multimedia (such as webcasts) which they could go through at their own pace and time before the coming to the scenarios learning. Crew resource management and multi-disciplinary collaboration-communication must be an integral part of any simulation training.

Dr. Bill HB CHAN
(Hong Kong)
O&G Simulation Training: Local Hospital Experience Sharing
Dr. Daniel WONG
(Hong Kong)
back to top
Colposcopy
Chairpersons: Dr. Wai-Hon LI, Dr. Nelson SS SIU
Cervical Cancer Screening – From Cytology to HPV Testing
Prof. Marion SAVILLE
(Australia)
HPV Vaccine
Cervical cancer is a global burden and still ranked 7th in Hong Kong. There was a slow increase in trend in past years and primary prevention is better than secondary prevention. HPV being an essential causative infection in cervical cancer, preventing its infection can prevent cervical cancer. The current 3 commercial HPV vaccines are highly effective in preventing specific HPV infection. Their effectiveness and safety shown in randomized control studies also included data from Hong Kong. Post marketing surveillance and recommendation from WHO confirmed that these vaccines are safe despite some adverse reports especially from Japan. In 2018, the HK SAR Government announced the plan to implement HPV vaccination to young girls as government free vaccination program. To maximize effective prevention, good coverage, good planning and preparation are much needed. Acceptability is one of major challenge in high uptake. School based program seems so far to be most effective in achieving a high coverage. Our previous studies showed that school based education improved on knowledge and acceptability of teenagers to HPV vaccination. Educating parents and community are as important. Our previous study showed that effectiveness and side-effects were main concern. Thus, education pamphlets or talks should address these potential concerns. Though the vaccines is most effective before sexual exposure, information on potential benefit after sexual exposure is also needed for self -funded vaccination. Furthermore, implementation of population vaccination need good planning with cross- department co-ordination, attentions to logistics. A good registry need to be set up to monitor the uptake and possibly on effectiveness. In future, need to address whether boys should be vaccinated and impact on the screening program. To make the program successful, all professional should take part in its preparation and implementation.
Prof. Hextan YS NGAN
(Hong Kong)
HPV DNA Self-sampling for Cervical Cancer Screening
Prof. Eliza LY WONG
(Hong Kong)
back to top
Oncology
Chairpersons: Dr. Ka-Yu TSE, Dr. Assumpta SM WONG
One Year On. The LACC Trial and How the Surgical Care of Women with Early Cervical Cancer Has Changed
Dr. Joseph SY NG
(Singapore)
Lynch Syndrome and its Clinical Relevance in Gynaecological Cancer Prof. Suet-Yi LEUNG
(Hong Kong)
Adjuvant Intraperitoneal Chemotherapy experience in Hong Kong- Case report and systemic review of the evidence
One third of the patients in Hong Kong belong to the advanced stages (III and IV) for ovarian malignancies. Complete cytoreduction surgery and adjuvant chemotherapy are advocated in management algorithms to optimize clinical outcome. Intraperitoneal chemotherapy is a valid option with theoretical advantage to achieve sustained, high concentration of antitumor activity, and studies over the past decade have demonstrated improved progression-free and overall survival. But it is not widely adopted due to concerns over toxicity and technical challenge, and in Hong Kong this is rarely done. This study aims to illustrate two patients with completion of intraperitoneal chemotherapy and provide latest systemic review for such evidence.

Two patients with stage III ovarian cancer have completed intraperitoneal chemotherapy under the Armstrong regimen from October 2018 to March 2019. Patient 1 received upfront complete debulking surgery for stage III ovarian cancer with insertion of intraperitoneal port, followed by adjuvant 24-hour intravenous taxol (135mg/m2) on day 1, intraperitoneal cisplatin (75mg/m2) on day 2, intraperitoneal taxol (60mg/m2) on day8, every 3 weeks for total of six cycles. Patient 2 with stage III ovarian cancer received neoadjuvant intravenous taxol and carboplatin, every 3 weeks for three cycles, followed by interval debulking surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) and complete resection. Intraperitoneal chemotherapy using Armstrong regimen followed for three more cycles. Both patients completed treatment with no major toxicity. Systematic review of large phase III randomized trials was done to justify the demonstrated survival benefit. Toxicities are in general higher for intraperitoneal chemotherapy but one study demonstrated that the Quality of Life at one year is equivalent in both arms, while another study showed dose reduction necessary for both arms. In the era of novel targeted therapy and dose intensification for chemotherapy, patient selection for intraperitoneal chemotherapy is very important for safe and efficacious administration.
Dr. Amy TY CHANG
(Hong Kong)
back to top
Ultrasound
Chairpersons: Prof. Kwok-Yin LEUNG, Dr. Felix WONG
Ultrasonography of Pelvic Endometriosis and Adenomyosis
The accurate diagnosis of endometriosis and adenomyosis is essential to determine the best treatment strategy. Non-invasive imaging techniques are needed to evaluate accurate diagnosis of the location and extent of endometriosis. Transvaginal ultrasonography (TVUS) is the initial test for the diagnosis of pelvic endometriosis and adenomyosis. For indeterminate masses on TVUS, MRI is used as a problem solving technique and seems to be useful in diagnosing all locations of endometriosis and adenomyosis. In this presentation, diagnostic accuracy of TVUS in pelvic endometriosis and adenomyosis, as well as comparison with MRI, will be demonstrated, and US findings of pelvic endometriosis and adenomyosis including the differential diagnosis will be reviewed. Furthermore, the main limitations of TVUS will be discussed.
Prof. Chan-Kyo KIM
(South Korea)
Ultrasonography of Endometrial Neoplasm
Transvaginal ultrasonography (TVUS) has become the first imaging to evaluate postmenopausal bleeding that is most common initial symptom of endometrial cancer. The use of pretreatment imaging modality is increasingly requested for identifying risk stratification in endometrial cancer. High-risk cancer is considered as the presence of deep myometrial invasion, cervical stromal invasion, or high grade tumor. TVUS is a useful tool to evaluate the location and extent of endometrial cancer, with similar accuracy with MRI. This presentation will review the US features and diagnostic accuracy of assessing local delineation and extent in endometrial cancer as well as comparison with MRI. Also, with the use of TVUS, potential role of stratifying the risk in endometrial cancer and limitations will be addressed.
Prof. Chan-Kyo KIM
(South Korea)
Focused Ultrasound Therapy for Fibroid and Adenomyosis
Dr. Vincent YT CHEUNG
(Hong Kong)
back to top
Endoscopy
Chairpersons: Dr. Eva CW CHEUNG, Dr. Eric TC LEE
Pearls and Strategies in Surgical Management of Deep Infiltrative Endometriosis, Large Uterus and Frozen Pelvis
Prof. Alan LAM
(Australia)
Pearls and Pitfalls of LASH
Dr Leslie SF LO
(Hong Kong)
How to Prevent and Deal with Complications in MIS
Prof. Alan LAM
(Australia)
back to top
Urogynaecology
Chairpersons: Dr. Wing-Wa GO, Dr. Willy Cecilia CHEON
Contemporary Management of Overactive bladder
I plan to discuss contemporary medical management of Overactive bladder in women, citing evidence from literature, covering areas involving conservative management, use of medications, treatment of refractory OAB.
Dr. Joseph LEE
(Australia)
Conservative Management of Pelvic Organ Prolapse
Dr. To WONG
(Hong Kong)
Pelvic Floor USS for gynaecologists - WHY?
Perineal ultrasound can reveal most structures of interest in pelvic floor disorders in the near field, at high frequencies, and with sufficient clarity due to excellent tissue discrimination between urethra, bladder, vagina, anorectum and levator muscle. Its ability to quantify organ descent, evaluate levator muscle integrity & its dynamic ballooning, as well as the anorectal complex is well described.

This presentation seeks to clarify how it could be useful for the clinician in their approach to complex pelvic floor disorders, assisting understanding pathophysiological basis for recurrence of incontinence/prolapse, why mesh/tape failed, excluding other important pathologies, ascertaining risk of recurrence and possibly help clinicians contemplating mesh removals.
Dr. Joseph LEE
(Australia)
An Observational Follow-up Study on Pelvic Floor Disorders to 3–5 Years After Delivery Dr. Karen NG
(Hong Kong)
The Prevalence of Obstetric Anal Sphincter Injury Following Vaginal Delivery in Primiparous Women Dr. Sonia PK Kwok
(Hong Kong)
back to top
Reproductive Medicine
Chairpersons: Dr. Calvin K.F. LEE, Dr. Ingrid Lok
Male Infertility
Semen factors alone account for nearly one-third of fertility problems and are present in around half of all couples who seek fertility treatment. Hence a simple semen analysis often avoids putting many women through the risks and discomforts of unnecessary invasive and expensive investigations such as laparoscopy.

Male infertility has been somewhat overlooked in the past because of the relative lack of effective treatments. Previous treatments trying to change semen parameters using medical or surgical means were generally ineffective because the majority of semen defects/variants are constitutional problems or under cryptic genetic control, except for some mostly easily identified situations such as significant systemic illnesses, rare hormone deficiencies, infections or exposure to toxins.

The development of IVF and intracytoplasmic sperm injection (ICSI) revolutionised the treatment of male infertility by directly assisting the sperm to fertilise the egg, which cannot be achieved efficiently in nature when semen defects are present. Such approach has even helped many men with non-obstructive azoospermia to conceive their biological children. New surgical technique of microdissection for testicular extraction (microTESE) not only provides better sperm recovery but also minimises damages to or loss of testicular tissue and reducing complications.

The ability to bypass natural selection processes in men with infertility makes it important to ensure genetic materials passed are not damaged or defective which can lead to treatment failures, miscarriages or babies born with abnormalities. These include sperm DNA fragmentation, chromosomal numerical or structural abnormalities and many known gene mutations, which are found much more often in men with semen defects. Sperm DNA fragmentation are mostly acquired and hence can be treated or avoided. Chromosomal or genetic defects though cannot be corrected but the affected embryos can be identified through Preimplantation genetic diagnosis (PGD) and avoided from being transferred and conceived.
Dr. Derek LOK
(Australia)
International Evidence-based Guideline on the Assessment and Management of PCOS
Previous guidelines either lacked rigorous evidence-based processes, failed to engage consumer and international multidisciplinary perspectives or were outdated. Diagnosis of PCOS remains controversial and assessment and management are inconsistent. The needs of women with PCOS are not being adequately met and evidence practice gaps persist.

International evidence-based guideline development engaged professional societies and consumer organisations with multidisciplinary experts and women with PCOS directly involved at all stages. Appraisal of Guidelines for Research and Evaluation (AGREE) II-compliant processes were followed, with extensive evidence synthesis. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied across evidence quality, feasibility, acceptability, cost, implementation and ultimately recommendation strength.

The evidence in the assessment and management of PCOS is generally of low to moderate quality. The guideline provides 31 evidence based recommendations, 59 clinical consensus recommendations and 76 clinical practice points. Key changes in this guideline include i) considerable refinement of individual diagnostic criteria with a focus on improving accuracy of diagnosis ii) reducing unnecessary testing iii) increased focus on education, lifestyle modification, emotional wellbeing and quality of life iv) emphasizing evidence based medical therapy and cheaper and safer fertility management.

The international guideline for the assessment and management of PCOS provides clinicians with clear advice on best practice based on the best available evidence, expert multidisciplinary input and consumer preferences. Research recommendations have been generated and a comprehensive multifaceted dissemination and translation programs supports the guideline with an integrated evaluation program.
Prof. Ernest HY NG
(Hong Kong)
Fertility Preservation in Females
With the advancement in diagnosis and treatment of cancer, the overall survival rate in young cancer patients has increased. However, anti-cancer treatment including chemotherapy and radiotherapy are often highly detrimental to the female endocrine and reproductive function.

The fecundity of these young cancer survivors becomes the key quality of life issue after their recovery. Despite the existence of multiple international guidelines for clinical practitioners on the issue of fertility preservation, many physicians still initiate anti-cancer treatment without detailed consultation on post-treatment fertility.

Fertility preservation refers to the means to preserve the women’s hormonal function as well as fertility from the damage of anti-cancer treatment. A variety of fertility preservation strategies are available and the option of fertility preservation should be individualized for each patient. This presentation aims to discuss the various options of fertility preservation available, especially those involving assisted reproductive technology with embryo and oocyte freezing and an individualized approach will be shared.
Prof. Jacqueline CHUNG
(Hong Kong)
Effect of Mid-follicular Phase Recombinant LH versus Urinary HCG Supplementation in Poor Ovarian Responders Undergoing IVF – A Prospective Double-Blinded Randomized Study Dr. Jennifer SM MAK
Independent Association of Serum Vitamin D with Anti-Mullerian Hormone Levels in Women with Polycystic Ovary Syndrome Dr. Queenie HY WONG
back to top

SPONSORED LUNCH SYMPOSIA

1 June Lunch Symposium (Sponsored by Bayer)
Chairperson: Dr. Edward YAU
Nutritional and Supplementation Needs at Different Stages of Pregnancy and Lactation
Prof. Berthold KOLETZKO
(Germany)
back to top
2 June Lunch Symposium (Sponsored by GSK)
Chairperson: Prof. Wing-Hung TAM
Local Situation of Pertussis and Maternal Immunisation Dr. David Christopher LUNG (Hong Kong)
Importance of Maternal Immunization against Pertussis Dr. Philippe BUCHY (France)
back to top